Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies against human CD39 and use thereof for inhibiting T regulatory cells activity

Antibodies against human CD39 and use thereof for inhibiting T regulatory cells activity

US Patent 11685792 · Granted Jun 27, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies having specificity for CD38 and uses thereof2025
Ex vivo generation of MHCII restricted CD4+ FOXP3+ regulatory T cells and therap2022
Methods and compositions for treating and preventing HIV2022
Ex vivo generation of γδ Foxp3+ regulatory T cells and therapeutic uses thereof2021
Monoclonal antibodies binding to the CD160 transmembrane isoform2021
Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides2021
Methods and compositions for treating and preventing HIV2020
Diagnostic markers of immunosenescence and methods for determining the susceptib2020
Antibodies against human CD39 and use thereof for inhibiting T regulatory cells 2020
Antibodies against human CD39 and use thereof for inhibiting T regulatory cells 2020
Antibodies against human CD39 and use thereof for inhibiting T regulatory cells 2020
Antibodies against human CD39 and use thereof for inhibiting T regulatory cells 2020